Michele Navarra

Prof. Michele Navarra

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
CRCaterina Russo
Caterina Russo
Alessandro MaugeriAlessandro Maugeri
Alessandro Maugeri
GLGiovanni Enrico Lombardo
Giovanni Enrico Lombardo
LMLaura Musumeci
Laura Musumeci
Davide BarrecaDavide Barreca
Davide Barreca
Michele NavarraMichele Navarra
Michele Navarra
Citrus fruits (CF) are among the most widely cultivated fruit crops throughout the world and their production is constantly increasing along with consumers’ demand. Therefore, huge amounts of waste are annually generated through CF processing, causing high costs for their disposal, as well as environmental and human health damage, if inappropriately performed. According to the most recent indications of an economic, environmental and pharmaceutical nature, CF processing residues must be transformed from a waste to be disposed to a valuable resource to be reused. Based on a circular economy model, CF residues (i.e., seeds, exhausted peel, pressed pulp, secondary juice and leaves) have increasingly been re-evaluated to also obtain, but not limited to, valuable compounds to be employed in the food, packaging, cosmetic and pharmaceutical industries. However, the use of CF by-products is still limited because of their underestimated nutritional and economic value, hence more awareness and knowledge are needed to overcome traditional approaches for their disposal. This review summarizes recent evidence on the pharmacological potential of CF waste to support the switch towards a more environmentally sustainable society.

2 March 2015 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Michele NavarraMichele Navarra
Michele Navarra
CMCarmen Mannucci
Carmen Mannucci
MDMarisa Delbò
Marisa Delbò
Gioacchino CalapaiGioacchino Calapai
Gioacchino Calapai
Citrus bergamia Risso et Poiteau, also known as “Bergamot”, is a plant belonging to the Rutaceae family, defined as a hybrid of bitter orange and lemon. It is an endemic plant of the Calabria region (Italy). Bergamot fruit is primarily used for the extraction of its essential oil (bergamot essential oil: BEO), employed in perfume, cosmetics, food and confections. The aim of this review was to collect recent data from the literature on Citrus bergamia essential oil and, through a critical analysis, focus on safety and the beneficial effects on human health. Clinical studies on the therapeutic applications of BEO exclusively focus on the field of aromatherapy, suggesting that its use can be useful for reducing anxiety and stress.

1 December 2013 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MMM. Miroddi
M. Miroddi
Gioacchino CalapaiGioacchino Calapai
Gioacchino Calapai
Michele NavarraMichele Navarra
Michele Navarra
PMP.L. Minciullo
P.L. Minciullo
SGSebastiano Gangemi
Sebastiano Gangemi

30 March 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Santa CirmiSanta Cirmi
Santa Cirmi
AAAsmae El Abd
Asmae El Abd
LLLouis Letinier
Louis Letinier
Michele NavarraMichele Navarra
Michele Navarra
FSFrancesco Salvo
Francesco Salvo
Tyrosine kinase inhibitors (TKIs), the treatment of choice for chronic myeloid leukemia (CML), can be associated to cardiovascular (CV) adverse events (AEs). A case/non-case study was performed using AE reports registered in the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database to compare the risk of CV event reports related to TKIs indicated in the management of chronic myeloid leukemia (CML). Disproportionality of CV event-related TKIs was computed using the Reporting Odds Ratio (ROR) as a measure of potential risk increase. Nilotinib accounts for more than half of reported cases related to TKIs. Signal of Disproportionate Reporting (SDR) was found for cardiac failure, ischemic heart disease, cardiac arrhythmias, torsade de pointes/QT prolongation, hypertension, and pulmonary hypertension. Dasatinib and bosutinib were related to the highest disproportionality for cardiac failure. Nilotinib was associated with the highest SDR for ischemic heart disease, torsade de pointes/QT prolongation and cardiac arrhythmias. Only ponatinib was related to an SDR for hypertension, while dasatinib and imatinib were related to pulmonary hypertension. In the context of CML, TKIs have different safety profiles related to CV events, among which nilotinib seems particularly related to. These results claim for a revision of its CV safety profile mainly for the risk of torsade de pointes/QT prolongation.

5 December 2014 in Urologia Internationalis
Verified
Journal Article
Open access
PDF file
PMPaola Lucia Minciullo
Paola Lucia Minciullo
AIAntonino Inferrera
Antonino Inferrera
Michele NavarraMichele Navarra
Michele Navarra
Gioacchino CalapaiGioacchino Calapai
Gioacchino Calapai
CMCarlo Magno
Carlo Magno
SGSebastiano Gangemi
Sebastiano Gangemi
Background: Several parameters including inflammatory mediators, hormones, dietary factors, inflammatory genes, and oxidative stress (OS) have been considered to play a role in the development of benign prostatic hyperplasia (BPH). Prostate tissue damage and OS may lead to compensatory cellular proliferation with resulting hyperplastic growth. Methods: We searched MEDLINE for articles in English published up to March 2014 using the key words ‘oxidative stress', ‘antioxidants' and ‘benign prostatic hyperplasia'. Results: Prostatic inflammation can cause the generation of free radicals. The extent of oxidative damage can be exacerbated by a decreased efficiency of antioxidant defense mechanisms. The balance between OS and the antioxidant component also has a role in developing prostate disease. Several works show the role of oxidant products and of depletion of antioxidant substances in BPH patients. It is accepted that free radicals play a role in carcinogenesis and that BPH should be considered a premalignant condition which may evolve into prostate cancer. High OS parameters and low antioxidant activity are more prominent in prostate cancer patients compared with BPH and controls. Conclusions: Further studies are needed to clarify the potential role of antioxidants in BPH also in view of preventing the progression to prostate cancer.

1 December 2013 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
CCChristian Celia
Christian Celia
ETElena Trapasso
Elena Trapasso
Marcello LocatelliMarcello Locatelli
Marcello Locatelli
Michele NavarraMichele Navarra
Michele Navarra
Cinzia Anna VenturaCinzia Anna Ventura
Cinzia Anna Ventura
Donatella PaolinoDonatella Paolino
Donatella Paolino